Published in J Neurooncol on October 08, 2011
Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge. Nat Rev Cancer (2014) 2.10
Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat. Breast Cancer Res (2012) 1.51
Triple-negative breast cancer: new perspectives for targeted therapies. Onco Targets Ther (2015) 1.14
Antiangiogenic therapy for glioblastoma: current status and future prospects. Clin Cancer Res (2014) 1.12
Epigenetic treatment of solid tumours: a review of clinical trials. Clin Epigenetics (2015) 0.96
Profile of panobinostat and its potential for treatment in solid tumors: an update. Onco Targets Ther (2013) 0.92
DCE and DW-MRI monitoring of vascular disruption following VEGF-Trap treatment of a rat glioma model. NMR Biomed (2011) 0.90
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors. Br J Cancer (2014) 0.89
Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies. Cancers (Basel) (2013) 0.89
Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat). Breast Cancer Res Treat (2012) 0.86
Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma. Neuro Oncol (2015) 0.85
Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors. Cancer Chemother Pharmacol (2012) 0.84
Dosing de novo combinations of two targeted drugs: Towards a customized precision medicine approach to advanced cancers. Oncotarget (2016) 0.81
Developing epigenetic diagnostics and therapeutics for brain disorders. Trends Mol Med (2013) 0.78
Convection enhanced delivery of panobinostat (LBH589)-loaded pluronic nano-micelles prolongs survival in the F98 rat glioma model. Int J Nanomedicine (2017) 0.75
New Directions in Anti-Angiogenic Therapy for Glioblastoma. Neurotherapeutics (2017) 0.75
Therapeutic Targeting of Histone Modifications in Adult and Pediatric High-Grade Glioma. Front Oncol (2017) 0.75
Blood-brain barrier-adapted precision medicine therapy for pediatric brain tumors. Transl Res (2017) 0.75
Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence. Neurology (2008) 8.10
The DNA sequence and comparative analysis of human chromosome 20. Nature (2002) 7.40
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst (2001) 4.69
Reversed cerebral asymmetry in women with breast cancer. Lancet (1992) 3.04
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation. Proc Natl Acad Sci U S A (2009) 2.72
The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42
Radiosurgery as part of the initial management of patients with malignant gliomas. J Clin Oncol (1992) 2.40
Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2000) 2.32
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas. J Clin Oncol (2000) 2.22
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol (2011) 2.13
Beta subunits promote K+ channel surface expression through effects early in biosynthesis. Neuron (1996) 2.05
Optic neuropathy in patients with glioblastoma receiving bevacizumab. Neurology (2009) 1.84
Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine. J Clin Oncol (2001) 1.82
The treatment of recurrent brain metastases with stereotactic radiosurgery. J Clin Oncol (1990) 1.76
Cloning of the 62-kilodalton component of basic transcription factor BTF2. Science (1992) 1.74
The physical maps for sequencing human chromosomes 1, 6, 9, 10, 13, 20 and X. Nature (2001) 1.63
Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst (1995) 1.56
PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling. Oncogene (2011) 1.54
Fixed drug combinations and the displacement of bilirubin from albumin. Pediatrics (1971) 1.54
Paraneoplastic opsoclonus-myoclonus associated with anti-Hu antibody. Neurology (1994) 1.54
Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the Egr-1 promoter: activation by ionizing radiation or uptake of radioactive iododeoxyuridine. Hum Gene Ther (1998) 1.50
Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Ann Oncol (2007) 1.47
Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report. Neurology (2008) 1.44
Pilot study of the combination of EGFR and mTOR inhibitors in recurrent malignant gliomas. Neurology (2006) 1.44
Integrative analysis reveals 53BP1 copy loss and decreased expression in a subset of human diffuse large B-cell lymphomas. Oncogene (2007) 1.40
Acute pulmonary toxicity in an infant from intravenous amiodarone. Am J Cardiol (1997) 1.40
Molecular analysis of pericentrin gene (PCNT) in a series of 24 Seckel/microcephalic osteodysplastic primordial dwarfism type II (MOPD II) families. J Med Genet (2009) 1.38
Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. Proc Natl Acad Sci U S A (1996) 1.37
The DNA sequence and analysis of human chromosome 13. Nature (2004) 1.33
Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs. ketoconazole. Rev Infect Dis (1990) 1.31
Mgmt methylation is a prognostic biomarker in elderly patients with newly diagnosed glioblastoma. Neurology (2009) 1.27
Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22. Oncogene (2010) 1.26
Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelines. Ann Oncol (2007) 1.24
Improved fluorescent PCR-based assay for sizing CGG repeats at the FRAXA locus. Clin Chem Lab Med (1999) 1.24
Single-stage posterolateral transpedicle approach for spondylectomy, epidural decompression, and circumferential fusion of spinal metastases. Spine (Phila Pa 1976) (2000) 1.22
Regional cerebral blood flow using quantitative MR angiography. AJNR Am J Neuroradiol (2007) 1.22
DNA sequence and analysis of human chromosome 9. Nature (2004) 1.21
A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals. Support Care Cancer (1996) 1.20
A phase II trial of temozolomide for patients with recurrent or progressive brain metastases. J Neurooncol (2001) 1.19
Molecular epidemiological study of nosocomial Enterobacter aerogenes isolates in a Belgian hospital. J Clin Microbiol (1998) 1.19
Radiological aspects of intra-uterine blood transfusion. Br J Radiol (1967) 1.18
Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery (1995) 1.18
Neonatal hypoglycaemia in infants of diabetic mothers given sulphonylurea drugs in pregnancy. Arch Dis Child (1970) 1.15
The DNA sequence and comparative analysis of human chromosome 10. Nature (2004) 1.14
Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. J Neurosurg (1999) 1.13
Morbidity and survival after 1,3-bis(2-chloroethyl)-1-nitrosourea wafer implantation for recurrent glioblastoma: a retrospective case-matched cohort series. Neurosurgery (1999) 1.12
Phase I trial of bortezomib and carboplatin in recurrent ovarian or primary peritoneal cancer. J Clin Oncol (2005) 1.12
Retrospective study of dasatinib for recurrent glioblastoma after bevacizumab failure. J Neurooncol (2010) 1.10
New treatment strategies for malignant gliomas. Oncologist (1999) 1.09
Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib. Ann Rheum Dis (2007) 1.09
Atypical presentation of Clostridium difficile colitis in patients with cystic fibrosis. AJR Am J Roentgenol (1999) 1.09
Ultrastructure of the 5-hydroxytryptamine3 receptor. J Neurochem (1995) 1.08
Monochorionic diamniotic minimally conjoined twins: a case report. Am J Med Genet (1990) 1.07
A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals. Eur J Cancer Care (Engl) (1996) 1.06
Metabolic aspects of the Beckwith-Wiedemann syndrome. J Pediatr (1973) 1.06
Complications of therapy for venous thromboembolic disease in patients with brain tumors. Neurology (1993) 1.05
Hepatitis B reactivation during glioblastoma treatment with temozolomide: a cautionary note. Neurology (2007) 1.05
Lipid metabolism in the neonate. II. The effect of Intralipid on bilirubin binding in vitro and in vivo. J Pediatr (1976) 1.03
Homology-driven assembly of a sequence-ready mouse BAC contig map spanning regions related to the 46-Mb gene-rich euchromatic segments of human chromosome 19. Genomics (2001) 1.02
Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma. Br J Cancer (2008) 1.02
Phase II study of phenylacetate in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report. J Clin Oncol (1999) 1.01
A new topical treatment for resistant herpes simplex infections. N Engl J Med (1993) 1.01
Radiographers as film readers in screening mammography: an assessment of competence under test and screening conditions. Br J Radiol (1996) 1.00
Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo. Nat Med (1996) 0.99
Comparison of sisomicin and gentamicin in bacteriuric patients with underlying diseases of the urinary tract. Antimicrob Agents Chemother (1975) 0.99
Gene therapy of malignant gliomas: a pilot study of vaccination with irradiated autologous glioma and dendritic cells admixed with IL-4 transduced fibroblasts to elicit an immune response. Hum Gene Ther (2001) 0.99
Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody. Br J Cancer (2009) 0.98
Risk of injury to cranial nerves after gamma knife radiosurgery for skull base meningiomas: experience in 88 patients. J Neurosurg (1999) 0.98
Inflammatory myofibroblastic tumor following hematopoietic stem cell transplantation: report of two pediatric cases. Bone Marrow Transplant (2004) 0.98
Proposed recommendations for the management of HIV post-exposure prophylaxis after sexual, injecting drug or other exposures in Europe. Euro Surveill (2004) 0.97
Lateral femoral cutaneous nerve block revisited. A nerve stimulator technique. Reg Anesth (1995) 0.97
Systemic metastasis in glioblastoma may represent the emergence of neoplastic subclones. J Neuropathol Exp Neurol (2000) 0.97
Low tidal volume ventilation is associated with reduced mortality in HIV-infected patients with acute lung injury. Thorax (2008) 0.96
Chemical thermogenesis in newborn infants: catecholamine excretion and the plasma non-esterified fatty acid response to cold exposure. Pediatrics (1966) 0.96
Somatic mutations are present in all members of the AKT family in endometrial carcinoma. Br J Cancer (2009) 0.96
Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study. J Clin Oncol (1997) 0.96
Spiritual and religious components of patient care in the neonatal intensive care unit: sacred themes in a secular setting. J Perinatol (2002) 0.95
Cyanide Degradation under Alkaline Conditions by a Strain of Fusarium solani Isolated from Contaminated Soils. Appl Environ Microbiol (1997) 0.95
Intramedullary spinal cord metastasis (ISCM) in renal cell carcinoma: a series of six cases. Ann Oncol (2001) 0.95
Amnesic syndrome in schizophrenia. Psychol Med (1990) 0.95
Quantitative analysis of cerebral asymmetries. Fronto-occipital correlation, sexual dimorphism and association with handedness. Arch Neurol (1986) 0.95
Central neurocytomas. Cancer (1997) 0.94
Metabolic effects of exchange transfusion. II. Delayed hypoglycemia following exchange transfusion with citrated blood. J Pediatr (1971) 0.94
Sephadex G-25 quantitative estimation of free bilirubin potential in jaundiced newborn infants sera: a guide to the prevention of kernicterus. J Lab Clin Med (1972) 0.94
Primary intracranial neoplasms in patients with HIV. Neurology (1999) 0.93
Lipid metabolism in the neonate. I. The effects of Intralipid infusion on plasma triglyceride and free fatty acid concentrations in the neonate. J Pediatr (1976) 0.93
Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma. Ann Oncol (2013) 0.93
Cerebral syphilitic gumma in an HIV-negative patient presenting as prolonged focal motor status epilepticus. N Engl J Med (1996) 0.92